Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1844-1845

  Albeniz Arbizu, E ^a   Barcena Marugan, R ^a,b   Oton Nieto, E ^a   Mateo Lindeman, M ^a   Garcia Gonzalez, M ^a   De Vicente Lopez, E ^a   Moraleda Garcia, G ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; CYCLOSPORIN; HEPATITIS B ANTIBODY; LAMIVUDINE; PREDNISONE; TACROLIMUS;

ADULT; AGED; ALLOGRAFT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG USE; FEMALE; GRAFT REJECTION; HEALTH CENTER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE;

EID: 0042833212     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00687-0     Document Type: Conference Paper

References (9)

1. Honaker M.R., Shokouh-Amiri M.H., Vera S.R., et al. Transpl Infect Dis. 4:2002;137.
2. MarKowitz J.S., Martin P., Conrad A.J., et al. Hepatology. 28:1998;585.
3. Bárcena R., Domínguez-Antonaya M., López A., et al. Transplant Proc. 31:1999;2457.
4. Angus P.W., McCaughan G.W., Gane E.J., et al. Liver Transpl. 6:2000;429.
5. Yoshida E.M., Erb S.R., Partovi N., et al. Liver Transpl Surg. 5:1999;520.
6. McCaughan G.W., Spencer J., Koorey D., et al. Liver Transpl Surg. 5:1999;512.
7. Grellier L., Mutimer D., Ahmed M., et al. Lancet. 348:1996;1212.
8. Huang E.J., Wright T.L., Lake J.R., et al. Hepatology. 23:1996;396.
9. Bárcena R., Fernández-Braso M., Urman J., et al. Transplant Proc. 31:1999;2459.